Founded in 1954 in Novo mesto, Slovenia, on the initiative of Boris Andrijanič, Krka, d. d., Novo mesto has developed into one of Europe’s leading generic pharmaceutical companies, combining in-house development, manufacturing, and international commercialization within a vertically integrated business model. Headquartered in Novo mesto, the company focuses on prescription pharmaceuticals, non-prescription products, and animal health, with a broad international presence spanning more than 70 countries and a strong position in Central and Eastern Europe. As of December 31, 2025, the Krka Group employed 13,281 people worldwide and reported revenue of €2.041 billion and net profit of €403.7 million, reflecting the scale, resilience, and growing international reach of a long-established European healthcare company.
Updated 2026-03-19